Revumenib Citrate
Revumenib (SNDX-5613) is a potent and selective small molecule inhibitor of the Menin-MLL interaction, used for researching MLL-rearranged leukemias such as ALL and AML. It has demonstrated activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a targeted therapeutic agent.
Product Specifications
CAS Number
2761046-45-9
Smiles
C (CC (O) =O) (CC (O) =O) (C (O) =O) O.C (N1CCC2 (CN (C2) C=3C (OC4=C (C (N (C (C) C) CC) =O) C=C (F) C=C4) =CN=CN3) CC1) [C@@H]5CC[C@@H] (NS (CC) (=O) =O) CC5.O
Molecular Formula
C38H57FN6O12S
Molecular Weight
840.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal Piccolo Antibody (PCLO-01) [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP2-62209R 0.1 mL
Mouse Monoclonal Piccolo Antibody (PCLO-01) [DyLight 550]
Sign In for Pricing
View Details 
K1156308 1.0 µg DNA
KLHL3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 